---
title: "ZEO Scientifix Awards Restricted Stock to CEO and CMO"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/273287393.md"
datetime: "2026-01-21T22:18:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/273287393.md)
  - [en](https://longbridge.com/en/news/273287393.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/273287393.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/273287393.md) | [繁體中文](https://longbridge.com/zh-HK/news/273287393.md)


# ZEO Scientifix Awards Restricted Stock to CEO and CMO

ZEO Scientifix Inc. has granted 175,000 restricted shares of common stock each to Chief Executive Officer and Chief Financial Officer Ian Bothwell and Chief Medical Officer Dr. George Shapiro under the company’s 2021 Incentive Stock Plan. The shares will vest in two installments: 50% after eight months from the award date and the remaining 50% after one year. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ZEO Scientifix Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001829126-26-000431), on January 21, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### 相关股票

- [Zeo ScientifiX, Inc. (ZEOX.US)](https://longbridge.com/zh-CN/quote/ZEOX.US.md)

## 相关资讯与研究

- [ZEO ScientifiX named official regenerative medicine education partner for A4M at Longevity SpringFest](https://longbridge.com/zh-CN/news/281186422.md)
- [ZEO Scientifix Inc. Files Initial Statement of Beneficial Ownership; John David Kisiday Named Chief Science Officer](https://longbridge.com/zh-CN/news/275178827.md)
- [ZEO Scientifix FY25 revenue rises 12.5% to USD 5.2 million](https://longbridge.com/zh-CN/news/274202278.md)
- [ZEO Scientifix Appoints Dr. John Kisiday as Chief Science Officer](https://longbridge.com/zh-CN/news/274045234.md)